Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 2A
Lee H et al. (2020)
|
Xla Wt + gpx3 MO
NF28 (RT-PCR)
|
|
|
|
Fig. 3 ABCD
Yang J et al. (2020)
|
Xla Wt + xbp1 MO
NF10 (in situ hybridization)
|
|
|
|
Fig.4.D
Ossipova O et al. (2020)
|
Xla Wt + pnhd-FLAG + animal cap explant
NF10.5-11 (RT-PCR)
|
|
|
|
Fig.4.B,C
Ossipova O et al. (2020)
|
Xla Wt + pnhd-FLAG + animal cap explant
NF11 (RNA-Seq)
|
|
|
|
Fig.4.D
Ossipova O et al. (2020)
|
Xla Wt + pnhd + animal cap explant
NF12 (RT-PCR)
|
|
|
|
Fig. 7 C
Sullivan CH et al. (2019)
|
Xla Wt + irx1
NF 16-NF 18 (in situ hybridization)
|
|
|
|
Fig 7 ADGJM (c1)
Deimling SJ and Drysdale TA (2011)
|
Xla Wt + Retinoic acid
NF18-20 (in situ hybridization)
|
|
|
|
Fig. 7 CFILO
Deimling SJ and Drysdale TA (2011)
|
Xla Wt + retinol
NF18-20 (in situ hybridization)
|
|
|
|
fig.5.c
Mir A et al. (2007)
|
Xla Wt + Activin + animal cap explant
NF11 (RT-PCR)
|
|
|
|
fig.5.c
Mir A et al. (2007)
|
Xla Wt + foxi1 MO + Activin + animal cap explant
NF11 (RT-PCR)
|
|
|